Early appearance of activated matrix metalloproteinase-9 after focal cerebral ischemia in mice: A possible role in blood-brain barrier dysfunction

被引:339
作者
Gasche, Y
Fujimura, M
Morita-Fujimura, Y
Copin, JC
Kawase, M
Massengale, J
Chan, PH
机构
[1] Stanford Univ, Neurosurg Labs, Dept Neurosurg, Palo Alto, CA 94304 USA
[2] Stanford Univ, Neurosurg Labs, Dept Neurol & Neurol Sci, Palo Alto, CA 94304 USA
[3] Stanford Univ, Program Neurosci, Palo Alto, CA 94304 USA
关键词
metalloproteinases; brain; ischemia; vasogenic edema; mice;
D O I
10.1097/00004647-199909000-00010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
During cerebral ischemia blood-brain barrier (BBB) disruption is a critical event leading to vasogenic edema and secondary brain injury. Gelatinases A and B are matrix metalloproteinases (MMP) able to open the BBB. The current study analyzes by zymography the early gelatinases expression and activation during permanent ischemia in mice (n = 15). ProMMP-9 expression was significantly (P < 0.001) increased in ischemic regions compared with corresponding contralateral regions after 2 hours of ischemia (mean 694.7 arbitrary units [AU], SD +/- 238.4 versus mean 107.6 AU, SD +/- 15.6) and remained elevated until 24 hours (mean 745.7 AU, SD +/- 157.4). Moreover, activated MMP-9 was observed 4 hours after the initiation of ischemia. At the same time as the appearance of activated MMP-9, we detected by the Evan's blue extravasation method a clear increase of BBB permeability. Tissue inhibitor of metalloproteinase-l was not modified during permanent ischemia at any time. The ProMMP-2 was significantly (P < 0.05) increased only after 24 hours of permanent ischemia (mean 213.2 AU, SD +/- 60.6 versus mean 94.6 AU, SD +/- 13.3), and no activated form was observed. The appearance of activated MMP-9 after 4 hours of ischemia in correlation with BBB permeability alterations suggests that MMP-9 may play an active role in early vasogenic edema development after stroke.
引用
收藏
页码:1020 / 1028
页数:9
相关论文
共 35 条
[1]   Differential matrix metalloproteinase expression in cases of multiple sclerosis and stroke [J].
Anthony, DC ;
Ferguson, B ;
Matyzak, MK ;
Miller, KM ;
Esiri, MM ;
Perry, VH .
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 1997, 23 (05) :406-415
[2]   Quantitative evaluation of blood-brain barrier permeability following middle cerebral artery occlusion in rats [J].
Belayev, L ;
Busto, R ;
Zhao, WZ ;
Ginsberg, MD .
BRAIN RESEARCH, 1996, 739 (1-2) :88-96
[3]  
Chan PH, 1996, ADV NEUROL, V71, P271
[4]  
CHEN H, 1992, NEUROSCI RES COMMUN, V11, P93
[5]   THE NEURONAL MICROENVIRONMENT - A COMPARATIVE VIEW [J].
CSERR, HF ;
BUNDGAARD, M .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1986, 481 :1-6
[6]   BRAIN EDEMA [J].
FISHMAN, RA .
NEW ENGLAND JOURNAL OF MEDICINE, 1975, 293 (14) :706-711
[7]   GELATINASE IN THE CEREBROSPINAL-FLUID OF PATIENTS WITH MULTIPLE-SCLEROSIS AND OTHER INFLAMMATORY NEUROLOGICAL DISORDERS [J].
GIJBELS, K ;
MASURE, S ;
CARTON, H ;
OPDENAKKER, G .
JOURNAL OF NEUROIMMUNOLOGY, 1992, 41 (01) :29-34
[8]   REVERSAL OF EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS WITH A HYDROXAMATE INHIBITOR OF MATRIX METALLOPROTEASES [J].
GIJBELS, K ;
GALARDY, RE ;
STEINMAN, L .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 94 (06) :2177-2182
[9]   INCREASED PRODUCTION OF GELATINASE-B (MATRIX METALLOPROTEINASE-9) AND INTERLEUKIN-6 BY ACTIVATED RAT MICROGLIA IN CULTURE [J].
GOTTSCHALL, PE ;
YU, X ;
BING, B .
JOURNAL OF NEUROSCIENCE RESEARCH, 1995, 42 (03) :335-342
[10]   Regulation of matrix metalloproteinase expression in astrocytes, microglia and neurons [J].
Gottschall, PE ;
Deb, S .
NEUROIMMUNOMODULATION, 1996, 3 (2-3) :69-75